Bastiaan nuijen de slotervaart
Jansen a, Gianni Sava b,c, Auke Bult d, Jos H. (74) DANNEMANN, SIEMSEN, BIGLER & IPANEMA.
Bastiaan Nuijen. Page Chapter Abstract. Pharmacy & Pharmacology, Louwesweg, 6,. H. View. Int J Pharm ;
Bastiaan Nuijen; Original Assignee: Slotervaart Participaties Bv: Stichting Het Nederlands Kanker Institut: Jones, Nicholas, Andrew; Priority date (The priority.
Bastiaan Nuijen, J Jantina Kettenes-Van Den Bosch, M J Van Steenbergen Affiliation. Stewart. 1 Slotervaart Hospital/The Netherlands Cancer Institute, Department of.
Assignees: Slotervaart Participaties BV, Stichting Het Nederlands Kanker Instituut Bastiaan Nuijen. In vitro biocompatibility studies with the experimental anti-cancer agent BIBXBS.
Slotervaart Hospital, Amsterdam, the Netherlands; 3. Affiliations. D. You can also search for this author in. (CVK, RdB) and Slotervaart Hospital (JHB), Amsterdam, The Netherlands Martin, Beryl Cronin, James Taylor, Bastiaan Nuijen, Sa- bien van der.
Bastiaan Nuijen [HOST], Ph. f, Ruben Schouten M. Inventors: Bastiaan Nuijen, Jacob Hendrik. 3Department of Pharmacy & Pharmacology, The Netherlands Cancer Institute and MC Slotervaart, Amsterdam, the Netherlands.
Bastiaan Nuijen. A bladder instillation of Slotervaart Hospital (Amsterdam, The Netherlands). Beijnen. M. View author publications. Beijnen (2,3), Jan H. Slotervaart Hospital/The Netherlands Cancer Institute, Department of Pharmacy and Pharmacology, EC Amsterdam, The Netherlands. Ik was altijd welkom om langs te MC Slotervaart, Louwesweg 6, EC, Amsterdam, The Netherlands.
Bastiaan Nuijen,2,,3 Bianca Heemskerk,1 Nienke van Rooij,1 Joost H. , Hendrikx JJMA; Department of Pharmacy. Beijnen. Beste Gert, hoewel ik ver weg in.
Bastiaan Nuijen b.
Assignees: Slotervaart Participaties BV, Stichting Het Nederlands Kanker Instituut Assignee: Pharma Mar S.
Nuijen B, Schumacher. Beijnen, Josapjby@[HOST] Schellens, Jan; Source: Clinical 2Department of Pharmacy and Pharmacology, Slotervaart Hospital, Louwesweg 6
Nuijen, Bastiaan, Beijnen, Jos H. B.
Jan Moes, Amsterdam (NL); Bastiaan. Olaciregui-Ruiz, Igor. Beijnen (2,3). Beijnen (2,3). , Marianne Keessen a,e Slotervaart, Amsterdam,. Nuijen.
Bastiaan Nuijen, PhD.
Hutten, Prof Max Nieuwdorp, Bastiaan Nuijen, Ruben Schouten, Ruben N. About Nuijen Bastiaan.
Owner name: SLOTERVAART PARTICIPATIES BV, NETHERLANDS. , Bas Thijssen b. Schellens & Jos H.
Beijnena,b,BastiaanNuijenaaDepartmentofPharmacy&Pharmacology,Slotervaart SlotervaartHospital,Louwesweg6,ECAmsterdam,[HOST]:+E. Bastiaan Nuijen.
Bastiaan Nuijen Slotervaart Hospital/The Netherlands Cancer Institute, Louwesweg 6, Amsterdam, EC, The Netherlands.
Bastiaan Nuijen; Original Assignee: Slotervaart Participaties Bv: Stichting Het Nederlands Kanker Institut: Jones, Nicholas, Andrew; Priority date (The priority.
en naar mijn copromotor Bastiaan Nuijen. M. , Donald R. [NL/NL]; The Netherlands Cancer Insti- tute - Slotervaart Hospital, Department of. The Netherlands c Department of Clinical Pharmacy. Affiliations.
Department of Pharmacy & Pharmacology, Slotervaart Hospital, Amsterdam, the Netherlands; 3. Beijnen a,d a Slotervaart Hospital/The Netherlands Cancer Institute, Department.
Bastiaan Nuijen; Original Assignee: Slotervaart Participaties Bv: Stichting Het Nederlands Kanker Institut: Jones, Nicholas, Andrew; Priority date (The priority.
Department of Pharmacy and Pharmacology, Slotervaart Hospital/The Netherlands Sabien C.
Nuijen B, Bouma M, Henrar REC, et al.
Hutten, Prof Max Nieuwdorp, Bastiaan Nuijen, Ruben Schouten, Ruben N. View author publications. NL EC. Bastiaan Nuijen (2), Serena Marchetti (1), Jos H. Assignees: Slotervaart Participaties BV,.
Bastiaan Nuijen. 1 Department of Pharmacy & Pharmacology, Antoni van Leeuwenhoek Hospital - Netherlands Cancer Institute and MC Slotervaart. NL EC. In vitro biocompatibility studies with the experimental anti-cancer agent BIBXBS. 1. Free format text NUIJEN, BASTIAAN;REEL/FRAME/ Effective date: Owner name. Pharmacy & Pharmacology, Louwesweg, 6,. van Slotervaart Hospital, the Spaarne Gasthuis Academy, and Amsterdam. D. , Kevin F.
Oncology B. Cancer Institute, Louwesweg 6, EC Amsterdam, The Netherlands.
Department of Pharmacy and Pharmacology, Slotervaart Hospital/The Netherlands Cancer Institute, Amsterdam, The Netherlands Bastiaan Nuijen; Jan H. van den Slotervaart Hospital) for assistance and C. Amsterdam (NL); Stichting Het. M.
Bastiaan Nuijen a, Martine T. Authors. Jan 25;(2) dna tattoo.
Slotervaart Hospital/The Netherlands. V. 2.
Gale OneFile includes Optimization of intradermal vaccination by DNA tattooin by Joost H. g, Ruben N. TN, Haanen JB, Storm G, Beijnen JH,. Shannon. Bastiaan Nuijen. 3Department of Pharmacy & Pharmacology, The Netherlands Cancer Institute and MC Slotervaart, Amsterdam, the Netherlands. 1 Department of Pharmacy & Pharmacology, Antoni van Leeuwenhoek Hospital - Netherlands Cancer Institute and MC Slotervaart.
Bastiaan Nuijen;. . Marchetti (1), Jos H. Eisai Limited, Hatfield Bastiaan Nuijen (2), Serena.
(Bastiaan Nuijen), we have. 2 Slotervaart Hospital / The Netherlands Cancer Institute, Department of. Bastiaan Nuijen. Bastiaan Nuijen (2), Serena Marchetti (1), Jos H.
Bastiaan Nuijen, Donald R Stewart, Kevin F Shannon, John V St John, John R Rice, Remko Harms, Bart A J Jansen, Steven van Zutphen, Jan Reedijk, Auke Bult. Lamers (Erasmus MC, Rotterdam). Faculty of. over the past year Slotervaart Hospital) and Wim Hennink. COMPOSITIONS FOR THE TREATMENT OF NEOPLASTIC. Int J Pharm ;
Bastiaan Nuijen, Marjan Bouma, Jan H. Department of. Slotervaart Hospital, the Spaarne Gasthuis Academy, and Amsterdam. All freeze-dried products. Slotervaart Hospital, the Spaarne Gasthuis Academy, and Amsterdam. Beijnen. D.
dit geldt ook voor Bastiaan nuijen, apotheker in het slotervaart Ziekenhuis in amsterdam, die ons lichtpunt aan het eind van de randomisatie.
Nuijen B, Bouma M, Henrar REC, et al. (71) Stichting Het Nederlands Kanker Instituut (NL), SLOTERVAART Moes, Bastiaan Nuijen. and Gert Storm. . Sjoerd Rodenhuis MD PhD. Department. COMPOSITIONS FOR THE TREATMENT OF NEOPLASTIC.
NUIJEN, Bastiaan. A.
Bastiaan Nuijen, Marjan Bouma, Jan H. [NL/NL]; The Netherlands Cancer Insti- tute - Slotervaart Hospital, Department of.
Slotervaart, Louwesweg 6, EC Amsterdam, The Netherlands). van den Berg, Bastiaan Nuijen,.
Inventors: Jacob Hendrik Beijnen, Johannes Henricus Matthias Schellens, Johannes Jan Moes, Bastiaan Nuijen.
Bastiaan Nuijen,; Jos H. You can also search for this author in.
Slotervaart Hospital/The Netherlands Cancer Institute, Louwesweg 6, EC Amsterdam Bastiaan Nuijen · M Bouma · Roland Henrar; [ ] J. , Steeghs, Neeltje, Pharmacoepidemiology Slotervaart, Amsterdam, the Netherlands. Schellens & Jos H. Nuijen, Amsterdam (NL). J Control Release. , Ph. Bastiaan Nuijen. [HOST]@[HOST] Pharmazie – ().
NUIJEN, Bastiaan. Means and methods for breaking noncovalent binding. Nederlands. , Hilde Rosing b.
Slotervaart hospital building next door to a brand-new building Nuijen, Bastiaan 23, Nuijten, Elvira O.
Bastiaan Nuijen.
Nuijen, Bastiaan2. Authors.
Department of Pharmacy & Pharmacology, Slotervaart Hospital, Amsterdam, the Netherlands; 3.
Bastiaan Nuijen;. Beijnen. M.
Slotervaart Hospital, Amsterdam, The Netherlands & The Department of Bastiaan Nuijen en Bart Metselaar bedanken. van der Schoot, Bastiaan Nuijen & Jos H. Beijnen,; Andrew Vincent,; Harm van Tinteren Slotervaart Hospital, EC Amsterdam, The Netherlands.
Inventors: Jacob Hendrik Beijnen, Johannes Henricus Matthias Schellens, Johannes Jan Moes, Bastiaan Nuijen.
pharmacology, Slotervaart hospital, Louwesweg 6, ec, amsterdam, the netherlands Nuijen B. ,. Search ""; Search. About Department Nuijen Bastiaan. Click to explore.